(Q42996032)

English

Mutations in the core and NS5A region of hepatitis C virus genotype 1b and correlation with response to pegylated-interferon-alpha 2b and ribavirin combination therapy

scientific article published in April 2011

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Mutations in the core and NS5A region of hepatitis C virus genotype 1b and correlation with response to pegylated-interferon-alpha 2b and ribavirin combination therapy (English)

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

1 reference

based on heuristic

inferred from title

Hepatitis C virus

1 reference

based on heuristic

inferred from title

6

object named as

I Nakano

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

1

object named as

K Hayashi

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

author name string

Y Katano

2

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

M Ishigami

3

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

A Itoh

4

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Y Hirooka

5

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

F Urano

7

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

K Yoshioka

8

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

H Toyoda

9

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

T Kumada

10

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

H Goto

11

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

publication date

1 April 2011

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Journal of Viral Hepatitis

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

18

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

4

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

280-286

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Evasion of intracellular host defence by hepatitis C virus

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2010.01305.X

21 January 2018

Control of PKR protein kinase by hepatitis C virus nonstructural 5A protein: molecular mechanisms of kinase regulation

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2010.01305.X

21 January 2018

Mutations in the nonstructural protein 5A gene and response to interferon in patients with chronic hepatitis C virus 1b infection

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2010.01305.X

21 January 2018

Why is the interferon sensitivity-determining region (ISDR) system useful in Japan?

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2010.01305.X

21 January 2018

Predictive factors of early and sustained responses to peginterferon plus ribavirin combination therapy in Japanese patients infected with hepatitis C virus genotype 1b: amino acid substitutions in the core region and low-density lipoprotein cholest

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2010.01305.X

21 January 2018

Mutations in the interferon sensitivity-determining region (nonstructural 5A amino acid 2209-2248) in patients with hepatitis C-1b infection and correlating response to combined therapy of pegylated interferon and ribavirin

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2010.01305.X

21 January 2018

Predictive values of amino acid sequences of the core and NS5A regions in antiviral therapy for hepatitis C: a Japanese multi-center study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2010.01305.X

21 January 2018

Evaluation of a new assay for hepatitis C virus genotyping and viral load determination in patients with chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2010.01305.X

21 January 2018

Prevalence and characterization of hepatitis C virus genotype 4 in Japanese hepatitis C carriers

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2010.01305.X

21 January 2018

Consensus proposals for a unified system of nomenclature of hepatitis C virus genotypes

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2010.01305.X

21 January 2018

Mutations in nonstructural protein 5A gene and response to interferon in hepatitis C virus genotype 2 infection

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2010.01305.X

21 January 2018

Mutations in the interferon sensitivity-determining region of hepatitis C virus genotype 2a correlate with response to pegylated-interferon-alpha 2a monotherapy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2010.01305.X

21 January 2018

Impact of asian race on response to combination therapy with peginterferon alfa-2a and ribavirin in chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2010.01305.X

21 January 2018

Mutations in E2-PePHD, NS5A-PKRBD, NS5A-ISDR, and NS5A-V3 of Hepatitis C Virus Genotype 1 and Their Relationships to Pegylated Interferon-Ribavirin Treatment Responses

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2010.01305.X

21 January 2018

Sequence variation in hepatitis C virus nonstructural protein 5A predicts clinical outcome of pegylated interferon/ribavirin combination therapy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2010.01305.X

21 January 2018

Telaprevir and peginterferon with or without ribavirin for chronic HCV infection

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2010.01305.X

21 January 2018

Telaprevir with peginterferon and ribavirin for chronic HCV genotype 1 infection

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2010.01305.X

21 January 2018

Pretreatment prediction of virological response to peginterferon plus ribavirin therapy in chronic hepatitis C patients using viral and host factors

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2010.01305.X

21 January 2018

Genome-wide association of IL28B with response to pegylated interferon-alpha and ribavirin therapy for chronic hepatitis C

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2010.01305.X

21 January 2018

Identifiers

10.1111/J.1365-2893.2010.01305.X

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42996032&oldid=1976289833"